ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.33
−1.48%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.35
From 52W high−97.97%
Volume55140.00
Market cap$3.35M
P/E (TTM)—
P/S (TTM)7.2x
Div yield—
Key dataSep 18, 2026
Open
$1.35
From 52W high
−97.97%
Volume
55140.00
Market cap
$3.35M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
30.6
MomentumView details →
1D Return
−1.48%
YTD Return
−87.02%
SummaryUpdated Jun 1, 2026
iSpecimen Inc. (NASDAQ:ISPC) is a biotechnology services company founded in 2009 and headquartered in Lexington, Massachusetts. The company went public in June 2021 through an initial public offering. iSpecimen operates as a technology-enabled marketplace that connects life science researchers with healthcare organizations that have access to human biological specimens needed for medical research and drug development.
Similar companies
Latest newsMore news →
iSpecimen Inc. agreed to acquire certain artificial intelligence software, models, source code, data rights, and intellectual property from Foldlab AI Ltd. for an aggregate purchase price of $4,500,000, consisting of $2,000,000 in cash and $2,500,000 in shares of common stock, subject to stockholder and Nasdaq approval.16d agoKatharyn Field departed as Chief Executive Officer of iSpecimen Inc., effective 2026-08-26, and was succeeded by Shahin Behroyan.20d ago